Trends in prenatal discussion and HIV testing, 1996-2001: Pregnancy risk assessment monitoring system

Maternal and Child Health Journal

Volumn 11, Issue 6, 2007, Pages 526-531

  Lansky, Amy ^a   Sansom, Stephanie L ^a   Harrison, Leslie L ^b   Stancil, Tonya ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

AIDS serodiagnosis; HIV infections; Mass screening; Pregnancy; Prenatal care

Indexed keywords

ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DECISION MAKING; DOCTOR PATIENT RELATION; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MASS SCREENING; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; STRATEGIC PLANNING; TREND STUDY;

FEMALE; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; PHYSICIAN-PATIENT RELATIONS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PRENATAL DIAGNOSIS; RISK ASSESSMENT; UNITED STATES;

EID: 35848967567     PISSN: 10927875     EISSN: 15736628     Source Type: Journal    
DOI: 10.1007/s10995-007-0197-0     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention. Recommendations of the US Public Health Services Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1994;43(RR-11):1-20.
2. Centers for Disease Control and Prevention. US Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Morb Mortal Wkly Rep 1995;44(RR-7):1-15.
3. Lansky A, Jones JL, Frey RL, et al. Trends in HIV testing among pregnant women-United States, 1994-1999. Am J Public Health 2001;91:1291-3.
4. Centers for Disease Control and Prevention. Prenatal discussion of HIV testing and maternal HIV testing-14 states, 1996-1997. MMWR Morb Mortal Wkly Rep 1999;48:401-4.
5. Centers for Disease Control and Prevention. Revised recommendations for HIV screening of pregnant women. MMWR Morb Mortal Wkly Rep 2001;50(RR-19):59-86.
6. Centers for Disease Control and Prevention. Advancing HIV prevention: New strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:329-32.
7. Centers for Disease Control and Prevention. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recommendations and Rep 2006;55(RR-14):1-17.
8. Centers for Disease Control and Prevention. HIV testing among pregnant women-United States and Canada, 1998-2001. MMWR Morb Mortal Wkly Rep 2002;51:1013-6.
9. Anderson JE, Santelli J, Mugalla C. Changes in HIV-related HIV preventive behavior in the US population: Data from national surveys, 1987-2002. J Acquir Imm Defic Syndr 2003;34:195-202.
10. Williams L, Morrow B, Lansky A, et al. Surveillance for selected maternal behaviors and experiences before, during, and after pregnancy, Pregnancy Risk Assessment Monitoring System (PRAMS), 2000. MMWR Surveill Summ 2003;52(SS-11):1-20.
11. Centers for Disease Control and Prevention (CDC). PRAMS model surveillance protocol. Atlanta Ga: 2003. Available from the Division of Reproductive Health, CDC, 4770 Buford Hwy, MS K-22, Atlanta, GA 30341.
12. Shulman HB, Colley Gilbert B, Lansky A. The Pregnancy Risk Assessment Monitoring System (PRAMS): Current methods and evaluation of 2001 response rates. Public Health Rep 2006;121:74-83.
13. CDC. Technical guidance on HIV counseling. MMWR Morb Mortal Wkly Rep 1993;42(RR-2):8-17.
14. American Academy of Pediatrics Committee on Fetus and Newborn, American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Guidelines for perinatal care. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; Washington, DC: American College of Obstetricians and Gynecologists, 2002.
15. SUDAAN. Release 9.0. Research Triangle Park, NC: Research Triangle Institute; 2005.
16. Wong VK, Silebi M. HIV testing of pregnant women: Risk factors [I44]. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 1996; Chicago.
17. Carusi D, Learman LA, Posner SF. Human immunodeficiency virus test refusal in pregnancy: A challenge to voluntary testing. Obstet Gynecol 1998;91:540-5.
18. Rivero Y, Fernandez MI, O'Sullivan MJ, et al. Effect of name reporting on HIV testing rates among women in prenatal care in Miami [43129]. Presented at: XII International Conference on AIDS; 1998; Geneva.
19. Royce RA, Water EB, Fernandez MI, et al., for the Perinatal Guidelines Evaluation Project. Barriers to universal prenatal HIV testing in 4 US locations in 1997. Am J Public Health 2001;91:727-33.
20. Tyroch AH, Kaups KL, Rohan J, et al. Pregnant women and car restraints: beliefs and practices. J Trauma-Injury Infect Crit Care 1999;46(2):241-5.
21. Beck LF, Morrow B. Impact of questionnaire changes on observed prevalence of prenatal counseling. Am J Epidemiol 2003;157(11):S53. Abstract 210.
22. Schrag S, Arnold K, Mohle-Boetani J, et al. Prenatal screening for infectious diseases and opportunities for prevention. Obstet Gynecol 2003;102:753-60.